Stocks and Investing Stocks and Investing
Fri, January 7, 2022

David Lewis Maintained (TMDX) at Hold with Decreased Target to $22 on, Jan 7th, 2022


Published on 2024-10-27 19:10:58 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "TransMedics Group, Inc." (TMDX) at Hold with Decreased Target from $33 to $22 on, Jan 7th, 2022.

David, nor any peers, have made any analyst calls on TMDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources